Quick Answer
FENNEC PHARMACEUTICALS INC. reported Total Assets of $70.55 million for fiscal year 2025.
FENNEC PHARMACEUTICALS INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $70.55M | +57.0% |
| 2024 | $44.95M | +67.3% |
| 2023 | $26.86M | +34.5% |
| 2023 | $19.98M | -25.8% |
| 2022 | $26.94M | +20.2% |
| 2021 | $22.41M | -28.7% |
| 2020 | $31.42M | +122.1% |
| 2019 | $14.15M | -38.4% |
| 2018 | $22.95M | -19.2% |
| 2017 | $28.40M | +615.0% |
| 2016 | $3.97M | +289.8% |
| 2015 | $1.02M | -57.0% |
| 2014 | $2.37M | +35.4% |
| 2013 | $1.75M | -25.9% |
| 2012 | $2.37M | -55.8% |
| 2011 | $5.35M | -10.7% |
| 2010 | $5.99M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $49.26M | -16.4% | +9.8% |
| June 30, 2025 | $44.88M | -28.9% | -3.3% |
| March 31, 2025 | $46.40M | -32.9% | +3.2% |
| December 31, 2024 | $44.95M | +67.3% | -23.7% |
| September 30, 2024 | $58.92M | +209.7% | -6.7% |
| June 30, 2024 | $63.16M | +225.0% | -8.7% |
| March 31, 2024 | $69.19M | +217.1% | +157.6% |
| December 31, 2023 | $26.86M | -0.3% | +41.2% |
- FENNEC PHARMACEUTICALS INC. showed an increase of +57.0% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, FENNEC PHARMACEUTICALS INC.’s total assets has grown by 1077.2% (from $5.99 million to $70.55 million).
- The most recent figure is from FENNEC PHARMACEUTICALS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: